Zobrazeno 1 - 10
of 25
pro vyhledávání: '"ES Medlock"'
Publikováno v:
Blood. 81:916-922
We studied the effect of recombinant human granulocyte colony- stimulating factor (rhG-CSF) administration to pregnant rats upon fetal and neonatal myelopoiesis. Pregnant rats were treated with rhG-CSF twice daily for 2, 4, and 6 days before parturit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41b4b63a36ad50768f642de2524513ce
https://doi.org/10.1182/blood.v81.4.916.bloodjournal814916
https://doi.org/10.1182/blood.v81.4.916.bloodjournal814916
Publikováno v:
Blood. 81(4)
Maternally administered recombinant human granulocyte colony- stimulating factor (rhG-CSF) has been shown to cross the placenta and induce a peripheral neutrophilia and increases in the marrow and spleen neutrophil storage pools in fetal and newborn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cb0f1a7249eee4456b5322a531a7b1a
https://pubmed.ncbi.nlm.nih.gov/7679008
https://pubmed.ncbi.nlm.nih.gov/7679008
Autor:
Kim MR; Departments of Functional Genomics, Pathology, Inflammation, Clinical Immunology, and Protein Science, Amgen Inc, Thousand Oaks, California 91302, USA. mkim@amgen.com, Manoukian R, Yeh R, Silbiger SM, Danilenko DM, Scully S, Sun J, DeRose ML, Stolina M, Chang D, Van GY, Clarkin K, Nguyen HQ, Yu YB, Jing S, Senaldi G, Elliott G, Medlock ES
Publikováno v:
Blood [Blood] 2002 Oct 01; Vol. 100 (7), pp. 2330-40.
Autor:
Augustine KA; Department of Cell Biology, Amgen Center, California, USA. karen_a_augustine@sbphrd.com, Rossi RM, Silbiger SM, Bucay N, Duryea D, Marshall WS, Medlock ES
Publikováno v:
The International journal of developmental biology [Int J Dev Biol] 2000 Jun; Vol. 44 (4), pp. 361-71.
Autor:
Augustine KA; Department of Cell Biology, Amgen, Inc., Thousand Oaks, California 91320, USA. karen_a_augustine@sbphrd.com, Silbiger SM, Bucay N, Ulias L, Boynton A, Trebasky LD, Medlock ES
Publikováno v:
The Anatomical record [Anat Rec] 2000 Mar 01; Vol. 258 (3), pp. 221-34.
Autor:
Perkins CP; Department of Molecular Genetics, Amgen, Inc., Thousand Oaks, California 91320, USA. cperkins@amgen.com, Mar V, Shutter JR, del Castillo J, Danilenko DM, Medlock ES, Ponting IL, Graham M, Stark KL, Zuo Y, Cunningham JM, Bosselman RA
Publikováno v:
Genes & development [Genes Dev] 1997 Apr 01; Vol. 11 (7), pp. 914-25.
Publikováno v:
Experimental hematology [Exp Hematol] 1994 Nov; Vol. 22 (12), pp. 1164-70.
Autor:
Simonet WS; Department of Developmental Biology, Amgen Center, Thousand Oaks, California 91320., Hughes TM, Nguyen HQ, Trebasky LD, Danilenko DM, Medlock ES
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 1994 Sep; Vol. 94 (3), pp. 1310-9.
Autor:
Medlock ES; Department of Pathology, School of Medicine, University of Connecticut Health Center, Farmington., McKenna SD, Goldschneider I
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 1993 Nov; Vol. 69 (5), pp. 616-28.
Autor:
Novales JS; Division of Neonatal-Perinatal Medicine, Memorial Miller Children's Hospital, Irvine, CA., Salva AM, Modanlou HD, Kaplan DL, del Castillo J, Andersen J, Medlock ES
Publikováno v:
Blood [Blood] 1993 Feb 15; Vol. 81 (4), pp. 923-7.